SIRT5 and metabolic dysfunction-associated steatotic liver disease: Given the independent mechanisms involved in progressive fibrosis by PNPLA3 rs738409 and SIRT5 rs12216101, these two variants might synergistically increase the risk of advanced fibrosis in MASLD.